✦ LIBER ✦

Cost-Effectiveness Analysis of the Addition of Rituximab to CHOP in Young Patients with Good-Prognosis Diffuse Large-B-Cell Lymphoma

✍ Scribed by Felicetto Ferrara, Dr Roberto Ravasio

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-Effectiveness Analysis of Rituximab

✍ Jennie H. Best; John Hornberger; Stephen J. Proctor; Louis F. Omnes; Fred Jost 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

Addition of rituximab to reduced-dose CH

✍ Ho-Jin Shin; Joo Seop Chung; Moo-Kon Song; Seon-Kyeong Kim; Sangmin Choe; Goon-J 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 423 KB

Cost-effectiveness of rituximab (MabTher

✍ M. T. Groot; P. J. Lugtenburg; J. Hornberger; P. C. Huijgens; C. A. Uyl-de Groot 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB

Rituximab in combination with CHOP chemo

✍ J. M. Li; L. Wang; Y. Shen; Z. G. Xia; Y. Chen; Q. S. Chen; Y. Chen; X. Y. Zeng; 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 161 KB

Serum BAFF predicts prognosis better tha

✍ Seok Jin Kim; Seung Jin Lee; In Young Choi; Yong Park; Chul Won Choi; In Sun Kim 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB

CHOP-like chemotherapy plus rituximab ve

✍ Michael Pfreundschuh; Lorenz Trümper; Anders Österborg; Ruth Pettengell; Marek T 📂 Article 📅 2006 🏛 The Lancet 🌐 English ⚖ 161 KB